Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac107Source: DataRank Database

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine is a research paper published in The Journal of Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.19)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Michelle E. Conroy ORCID,Vivek Naranbai,Upeka Samarakoon ORCID,Tina Motazedi,Jocelyn R. Farmer ORCID

Live enrichment

PubMed:35325158 PMC:PMC8992327 OpenAlex:https://openalex.org/W4220919306

NIAID NIH HHS

Grant: T32 AI007245

National Institutes of Health

Grant: 5T32AI007245-25

Molecular Basis of Viral Infectivity

National Institutes of Health

Grant: 3UM1AI109565-09S1

Immune Tolerance Network

Massachusetts General Hospital’s Transformational Scholar Award

FWCI

0.19

Citation Percentile

0.5%

Citation Trend

2022

2024

2026

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8992327

journalhttps://doi.org/10.1093/infdis/jiac107

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35325158

Europe_PMChttps://europepmc.org/articles/PMC8992327

Fields of Study

SARS-CoV-2 and COVID-19 ResearchDrug-Induced Adverse ReactionsMonoclonal and Polyclonal Antibodies Research03 medical and health sciences0302 clinical medicine

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Vaccines2019-nCoV Vaccine mRNA-1273HumansHypersensitivityImmunoglobulin GRNA, MessengerVaccinationImmunity, Humoral

Keywords

ImmunologyCoronavirusVaccinationAntibodyVirologyImmunoglobulin EMedicineRespiratory systemAntigenBiologyDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Internal medicineMessenger RNAHumoral immunityHypersensitivityanaphylaxisPfizerCovid-19Sars-cov-2ModernaSystems SerologyCOVID-19 VaccinesBrief ReportImmunity, HumoralImmunoglobulin GHumansRNA, Messenger2019-nCoV Vaccine mRNA-1273

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being